Benaroya Research Institute at Virginia Mason Medical Center

Seattle, Washington 98101

0 studies enrolling now · 10 studies all time

What they study most

Aids-related Malignancies, Anal Cancer, Anal Intraepithelial Neoplasia, Glioblastoma Multiforme, HIV Infection, High-grade Squamous Intraepithelial Lesion, Infection, Lymphoma, Neoplasm of Uncertain Malignant Potential, Nonneoplastic Condition, Precancerous Condition, Prostate Cancer

Studies at this site

• Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma — Completed
• Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions — Completed
• Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer — Completed
• Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection — Completed
• Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials — Completed
• Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma — Completed
• Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia — Completed
• Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus — Completed
• Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer — Status unconfirmed
• The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme — Completed